The co-primary endpoints were change from baseline in total nasal polyp size (measured by endoscopic ... tezepelumab’s potential as a new treatment for patients whose lives are disrupted by ...

Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) mainly to itself since June 2019, but GlaxoSmithKline’s Nucala is ...

Certain medications can help shrink or stop the growth of nasal polyps. Your healthcare provider can help you determine the ...

“The [Tezspire] data is clinically meaningful and offers patients with nasal polyps hope for a potential new treatment option that may reduce the burden on patients and healthcare systems.” Tezspire ...

Nasal sinusitis, commonly called a sinus infection, is a condition characterised by inflammation or swelling of the tissue ...

Participants in the trial were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]). Chronic rhinosinusitis with nasal polyps is a condition that can cause ...